Amacher, Simon A.
Sahmer, Christian
Becker, Christoph
Gross, Sebastian
Arpagaus, Armon
Urben, Tabita
Tisljar, Kai
Emsden, Christian
Sutter, Raoul
Marsch, Stephan
Hunziker, Sabina
Funding for this research was provided by:
Mach-Gaensslen Foundation Switzerland
Nora van Meeuwen Häfliger Stiftung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_169379, 10001C_192850/1)
Research Fund University of Basel
Scientific Society Basel
Gottfried und Julia Bangerter-Rhyner-Stiftung
Swiss Society of General Internal Medicine (10531C_182422)
Article History
Received: 1 November 2023
Accepted: 2 May 2024
First Online: 8 May 2024
Competing interests
: Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.